Literature DB >> 16500451

Relationship between rhinosinusitis symptoms and mucociliary clearance time.

Justin E Boatsman1, Karen H Calhoun, Matthew W Ryan.   

Abstract

OBJECTIVE: To determine the correlation between rhinosinusitis symptoms as assessed by the Sino-Nasal Outcomes Test-20 (SNOT-20) and mucociliary clearance as assessed by the saccharin method. STUDY DESIGN AND
SETTING: This was a cross-sectional study of 50 adult volunteers. Subjects completed the SNOT-20, and mucociliary clearance was determined with the saccharine method. Correlation coefficients (Spearman's Rho) were calculated for the global SNOT-20 score.
RESULTS: The SNOT-20 scores varied from 20 to 54 (mean 30.28) with a possible range of 20 to 100. Clearance times varied from 418 to 2865 seconds (mean 999). There was no significant correlation between global SNOT-20 score and clearance time (r = 0.196).
CONCLUSIONS: There is no significant correlation between rhinosinusitis symptoms as assessed by SNOT-20 scores and mucociliary clearance. SIGNIFICANCE: Mucociliary clearance is important for the health of the sinonasal cavities, but clearance time does not appear to be associated with symptom severity in the population studied. EBM RATING: A-1b.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16500451     DOI: 10.1016/j.otohns.2005.10.045

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  3 in total

1.  Quality of life in patients with chronic rhinosinusitis: a validation of the Czech version of SNOT-22 questionnaire.

Authors:  Petr Schalek; Lukás Otruba; Ales Hahn
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-12-24       Impact factor: 2.503

2.  Diagnostic strategies in nasal congestion.

Authors:  John Krouse; Valerie Lund; Wytske Fokkens; Eli O Meltzer
Journal:  Int J Gen Med       Date:  2010-04-08

3.  Spa therapy of upper respiratory tract inflammations.

Authors:  D Passali; E De Corso; S Platzgummer; C Streitberger; S Lo Cunsolo; G Nappi; G C Passali; L Bellussi
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-05-16       Impact factor: 2.503

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.